TrialThe Journal of infectious diseases2022

Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year Persistence.

Michael J Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.